Clinical Trials
2,182 trialsGC-CCP
RAND
TroFuse-020
Merck Sharp & Dohme LLC
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
PAROLA
Institut Claudius Regaud
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Alterome Therapeutics, Inc.
eVOLVE-02
AstraZeneca
PREDICT
Massachusetts General Hospital
HYPOCx-iRex
Siriraj Hospital
Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women
Women's Hospital School Of Medicine Zhejiang University
Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies
National Institutes of Health Clinical Center (CC)
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
M.D. Anderson Cancer Center
Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)
M.D. Anderson Cancer Center
PIKALO-1
Eli Lilly and Company
EXCEED
Eli Lilly and Company
NEXUS-01
Eli Lilly and Company
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Terremoto Biosciences Inc.
TroFuse-036
Merck Sharp & Dohme LLC
CASCADE3001A
UNC Lineberger Comprehensive Cancer Center
Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer
Tampere University Hospital
PAPAYA
Royal Marsden NHS Foundation Trust
COLTEP
University Hospital, Brest
PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer
M.D. Anderson Cancer Center
A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
RABBIT
University of Arizona
Biofeedback-Assisted Pelvic Floor Rehabilitation for Radiation-Induced Sexual Dysfunction in Cervical Cancer Survivors
Beni-Suef University
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
NRG Oncology
Impact of Education Methods on HPV Knowledge and Screening Behavior
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
CASCADE3002
UNC Lineberger Comprehensive Cancer Center
PostOP HYPOCxE
Siriraj Hospital
HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers
National Institutes of Health Clinical Center (CC)
OvAR-Y
Washington University School of Medicine
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mayo Clinic
PRIORITY
Pontificia Universidad Catolica de Chile
Keynote B59
GI Innovation, Inc.
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Daiichi Sankyo
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
New Phase Ltd.
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Peking University First Hospital
Education and Health in Women With Cervical Cancer
Federal University of Maranhao
Stereotactic Body Radiotherapy Boost Versus Simultaneous Integrated Boost to Pelvic Nodes Among Patients Receiving Radical Chemoradiation in Carcinoma Cervix
All India Institute of Medical Sciences
N01-A-PICIT-GT
Peking University People's Hospital
SHIP-A-S01
National Cancer Institute (NCI)
LMI-001-A-S03
National Cancer Institute (NCI)
LMI-001-A-S02
National Cancer Institute (NCI)
LMI-001-A-S04
National Cancer Institute (NCI)
ARTISAN
Peking Union Medical College Hospital
Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs
University of California, Los Angeles
Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment
UNC Lineberger Comprehensive Cancer Center
Bio-CHECC
University of Manchester
MK-2870-001
Klus Pharma Inc.